GSK3B and COVID-19: Additionally, the activation of several known tau-targeted kinases, including AMPK, glycogen synthase kinase 3 beta (GSK3β), protein kinase A (PKA), and calcium/calmodulin-dependent protein kinase II (CAMKII), was detected in the brains of COVID-19 patients [17].